A Novel 7-β-(4-Carboxybutanamido)-Cephalosporanic Acid Acylase Isolated from Pseudomonas Strain C427 and Its High-Level Production in Escherichia coli
スポンサーリンク
概要
- 論文の詳細を見る
We cloned the gene for 7-β-(4-carboxybutanamido)-cephalosporanic acid (GL-7ACA) acylase from Pseudomonas strain C427. The DNA sequence revealed an open reading frame of 2154bp coding for 718 amino acid residues. The deduced amino acid sequence consists of 4 structural domains : (i) a signal peptide (positions 1-27), (ii) a small subunit of the acylase (positions 28-190), designated as a, (iii) a spacer peptide (positions 191-198), (iv) a large subunit (positions 199-718), designated as β. Plasmids were constructed to dirct the synthesis of the acylase in Escherichia coli and the following results were obtained. The active acylase consists of two subunits which are processed from a single precursor protein, removing the spacer peptide during processing. A proportion of active acylase is secreted into the periplasm and the remainder is retained in the cytoplasm. The amount of precursor protein accumulated in the cytoplasm is greatly reduced when plasmids for the acylase lacking the signal sequence are expressed. Therefore, processing is independent of the translocation of the gene product through the cytoplasmic membrane, in contrast to the situation for penicillin G acylase. A high level of active enzyme production was achieved with a plasmid coding for an acylase in which the amino terminal sequence (positions 1-32) of native acylase is replaced by MFPTT.
- 社団法人日本生物工学会の論文
- 1994-06-25
著者
-
FUJIMURA TAKAO
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
ISHII YOSHINORI
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
SAITO YOSHIMASA
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
Ishii Y
Pharmacological Research Laboratories And Exploratory Research Laboratories
-
Fujimura Takao
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
KOJO Hitoshi
Advanced Technology Platform Research Laboratory Fujisawa Pharmaceutical Co., Ltd.
-
Ishii Yoshinori
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Ishii Y
Fermentation Development Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kojo H
Advanced Technology Platform Research Laboratory Fujisawa Pharmaceutical Co. Ltd.
-
Niwa Mineo
Pharmacological Research Laboratories And Exploratory Research Laboratories
-
Niwa Mineo
Institute For Medicinal Resources The University Of Tokushima
-
ISOGAI TAKAO
Fujisawa Pharmaceutical Co. Ltd.,
-
KOJO HITOSHI
Fujisawa Pharmaceutical Co. Ltd.,
-
YAMASHITA MITSUO
Pharmacological Research Laboratories and Exploratory Research Laboratories
-
KOHSAKA MASANOBU
Pharmacological Research Laboratories and Exploratory Research Laboratories
-
Niwa M
Institute For Medicinal Resources The University Of Tokushima
-
Isogai Takao
Fujisawa Pharmaceutical Co. Ltd.
-
Fujimoto Tamotsu
Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kohsaka Masanobu
Pharmacological Division, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
関連論文
- An Approach to High-Level Production of Cephalosporin Acylase from Pseudomonas strain N176 in Escherichia coli
- Purification and Molecular Characterization of a Quinoprotein Alcohol Dehydrogenase from Pseudogluconobacter saccharoketogenes IFO 14464
- Evaluation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtype Selectivity of a Variety of Anti-inflammatory Drugs Based on a Novel Assay for PPARδ(β)
- Comparative Characterization of New Glutaryl 7-ACA and Cephalosporin C Acylases
- Cloning and Nucleotide Sequencing of New Glutaryl 7-ACA and Cephalosporin C Acylase Genes from Pseudomonas Strains
- Isolation of Soil Strains Producing New Cephalosporin Acylases
- Direct Production of 7-Aminodeacetylcephalosporanic Acid by Acremonium chrysogenum Hm178(Microbiology & Fermentation Industry)
- Unique Properties of Coactivator Recruitment Caused by Differential Binding of FK614, an Anti-diabetic Agent, to Peroxisome Proliferator-Activated Receptor γ(Molecular and Cell Biology)
- FK614, a Novel Peroxisome Proliferator-Activated Receptor γ Modulator, Induces Differential Transactivation Through a Unique Ligand-Specific Interaction With Transcriptional Coactivators
- Direct Identification of a Novel Disulfide Bond Linkage System of New Isolated Isomer (Isomer V) in Recombinantly Produced h-IGF-I
- Synthesis of Two Possible Disulfide Bonds Containing Peptide Fragments(Cys^6-Cys^, Cys^-Cys^(Type I), and Cys^6-Cys^, Cys^-Cys^(Type II) of h-IGF-I) for the Identification of Disulfide Bond Linkage in Recombinantly Produced h-IGF-I
- Chemical Modification and Site-Directed Mutagenesis of Tyrosine Residues in Cephalosporin C Acylase from Pseudomonas Strain N176
- Affinity Labelling of Cephalosporin C Acylase from Pseudomonas sp. : N176 with a Substrate Analogue, 7β-(6-Bromohex-anoylamido)cephalosporanic Acid
- A Novel 7-β-(4-Carboxybutanamido)-Cephalosporanic Acid Acylase Isolated from Pseudomonas Strain C427 and Its High-Level Production in Escherichia coli
- Effect of flexion angle on coronal laxity in patients with mobile-bearing total knee arthroplasty prostheses
- Coronal laxity in extension in vivo after total knee arthroplasty
- Modulation of Alamethicin Assembly by Hybridization
- Preparation of Peptide Thioester Segments Using Fmoc-Solid-Phase Peptide Synthesis
- Large Scale Purification of Recombinant Insulin-Like Growth Factor I (IGF-I, Mecasermin) from a Fused Protein Produced in Escherichia coli
- An Approach to High-Level Production of Mecasermin (Somatomedin C) Fused Protein in Escherichia coli HB101
- Cloning and Nucleotide Sequences of the Complementary and Genomic DNAs for the Alkaline Protease from Acvemonium chrysogenum(Microbiology & Fermentation Industry)
- Effect of FK409, a Novel Nitric Oxide Donor, on Acute Experimental Myocardial Ischemia